The Report Autoimmune Disease Diagnostics Market Size & Forecast By Type (Systemic Autoimmune
Disease Diagnostics, Localized Autoimmune Disease Diagnostics Disease
Diagnostics), By Region, And Trend Analysis From 2018 To 2025
The global autoimmune disease diagnostics
market is expected to reach a value of USD 5.0 billion by 2025, based on a
new report by Grand View Research, Inc. Government organizations along with
related associations strive to curb such high healthcare costs and
simultaneously provide improved diagnostic and therapeutic solutions to the
patients. This has resulted in increased funding by the NIH for R&D
programs related to autoimmune diseases.
Moreover,
presence of favorable government initiatives aimed at curbing incidence of
these diseases and developing viable diagnostic & treatment options is
expected to drive market growth over the forecast period.
Growing
volume of autoimmune diagnostic procedures has heightened the need for
instruments and facilities rendering faster and effective results. In an
attempt to cater to ever-increasing procedure volumes, diagnostic laboratories
are rapidly moving toward automation. Lab automation helps decrease workload
via rapid turnaround times and helps generate standardized & reproducible
results.
Access Research Report of Autoimmune Disease Diagnostics Market @ www.grandviewresearch.com/industry-analysis/autoimmune-disease-diagnostics-industry
Further key findings
from the study suggest:
· Localized autoimmune disease diagnostics was the largest
segment in 2015 owing to high usage for type 1 diabetes and idiopathic
thrombocytopenic purpura
· Type 1 diabetes is estimated to grow at a significant
growth rate of over 4.0% in localized disease type segment
· Systemic disease diagnostics is anticipated to witness
lucrative CAGR of around 5.0% over the forecast period due to increasing
R&D for the development of novel diagnostic biomarkers for the treatment of
rheumatoid arthritis and systemic lupus erythematosus
· Rheumatoid arthritis is one of the most recurring
autoimmune disorders further demanding high amount of rapid diagnostics for
exploring better alternative treatments
· North America was the largest regional market in 2015.
High market penetration rate of technologically advanced products and increased
lab automation rate are some of the factors contributing to its large share
· Asia Pacific region is anticipated to grow at the fastest
CAGR of above 4.0% over the forecast period owing to increasing focus on type 1
diabetes diagnosis
· Some of the key players of this market include F.
Hoffmann-La Roche Ltd; Siemens Healthineers; Abbott Laboratories; Beckman
Coulter, Inc.; SQI Diagnostics; Quest Diagnostics; EUROIMMUN AG; AESKU.
Diagnostics; Inova Diagnostics, Inc.; Crescendo Bioscience, Inc.; bioMerieux
SA; Bio-Rad Laboratories, Inc.; and Hemagen Diagnostics, Inc.
Grand View Research has segmented the autoimmune disease
diagnostics market by type and region:
Autoimmune Disease
Diagnostics Type Outlook (Revenue, USD Million, 2014 - 2025)
·
Systemic autoimmune disease diagnostics
o Rheumatoid
arthritis
o Ankylosing
spondylitis
o Systemic
lupus erythematosus (SLE)
o Others
·
Localized autoimmune disease diagnostics
o Multiple
sclerosis
o Type 1
diabetes
o Hashimoto's
Thyroiditis
o Idiopathic
thrombocytopenic purpura
o Others
Autoimmune Disease
Diagnostics Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o China
o Japan
o India
·
Latin America
o Mexico
o Brazil
·
MEA
o South
Africa
Access
Press Release of Autoimmune Disease
Diagnostics Market @ www.grandviewresearch.com/press-release/global-autoimmune-disease-diagnostics-industry
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment